Journal Article Ppublish 18 citations
PubMed: 38528787 DOI: 10.1002/ejhf.3189
Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank.
Eur J Heart Fail 26(3):540-550
Authors: Jungeun Lim, Maryam Hashemian, Batel Blechter, Véronique L Roger, Jason Y Y Wong
Affiliations
- Epidemiology and Community Health Branch, National Heart Lung and Blood Institute, Bethesda, MD, USA.
- Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Abstract
AIMS
Serum sex hormones have been linked to cardiovascular disease risk. However, their roles in the pathogenesis of heart failure (HF) in both men and women are unclear. We investigated the associations between free androgen, testosterone, and estradiol, and future risk of HF.
METHODS AND RESULTS
This prospective cohort study evaluated UK Biobank participants free of prevalent cardiovascular disease and HF at baseline. Unitless free androgen, testosterone, and estradiol indices were generated using serum concentrations of total testosterone (nmol/L), estradiol (pmol/L), sex hormone binding globulin (SHBG, nmol/L), and albumin (g/L) in blood collected at enrolment. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of incident HF in relation to quartiles (Q) of free androgen (FAI), testosterone (FTI), estradiol (FEI) indices, and potential confounders. There were 180 712 men (including 5585 HF cases with FAI and 571 HF cases with FEI), and 177 324 women (including 2858 HF cases with FAI and 314 HF cases with FEI) with complete data. Increased FAI was associated with decreased HF risk in both men (HR Q4 vs. Q1: 0.86, 95% CI 0.79-0.94, p-trend continuous < 0.0001) and post-menopausal women (HR Q4 vs. Q1: 0.83, 95% CI 0.73-0.95). Similar inverse associations were observed for FTI only in men (HR Q4 vs. Q1: 0.91, 95% CI 0.83-0.98). Higher FEI was significantly associated with decreased HF risk among men (HR Q4 vs. Q1: 0.76, 95% CI 0.59-0.98), but was positively associated among pre-menopausal women (HR Q4 vs. Q1: 2.16, 95% CI 1.11-4.18).
CONCLUSIONS
Sex hormones potentially influence HF pathogenesis and may offer pathways for interventions.
MeSH
Estradiol, Heart Failure, Androgens, Heart, Cardiovascular Diseases, Cohort Studies, Hormones, Testosterone, Sex, Gonadal Steroid Hormones
Cited by
- Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women. Int J Mol Sci, 2025
- Sex Hormones and Heart Failure Risk. JACC Adv, 2025
- Sex Differences in Heart Failure: A Step Forward. Interv Cardiol, 2025
- Associations between mosaic loss of sex chromosomes and incident hospitalization for atrial fibrillation in the United Kingdom. medRxiv, 2024